Confluence of obesity and MAFLD during Covid‐19 pandemic in a developing country

The direct relation between the overweight/obesity, MAFLD and the severity SARS‐CoV‐2 infection. increase number of cases of obesity and MAFLD is an important risk factor for high mortality of COVID‐19 patients

Saved in:
Bibliographic Details
Published inEndocrinology, Diabetes & Metabolism Vol. 4; no. 2; pp. e00189 - n/a
Main Authors Gonzáles Yovera, Jhean Gabriel, Concepción‐Zavaleta, Marcio Jose, Coronado Arroyo, Julia, Moreno Marreros, Diego
Format Journal Article Web Resource
LanguageEnglish
Published England John Wiley & Sons, Inc 01.04.2021
John Wiley and Sons Inc
Wiley
Subjects
Biomarkers
Body mass index
Conflicts of interest
Coronaviruses
COVID-19
Developing Countries
Diabetes
Fatty Liver - epidemiology
Humans
LDCs
Literature reviews
Liver diseases
Metabolism
Mortality
Obesity
Obesity - epidemiology
Overweight
Pandemics
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Peru
Online AccessGet full text

Cover

More Information
Summary:The direct relation between the overweight/obesity, MAFLD and the severity SARS‐CoV‐2 infection. increase number of cases of obesity and MAFLD is an important risk factor for high mortality of COVID‐19 patients
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:2398-9238
2398-9238
DOI:10.1002/edm2.189